Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
2.030
+0.060 (3.05%)
Jan 23, 2025, 3:37 PM EST - Market open
STRO's stock price has decreased by -51.48% in the past year and price targets may not have had time to catch up.
Sutro Biopharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$12.14
Upside
+498.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +737.44% | Dec 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +491.13% | Nov 18, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $11 | Buy | Reiterates | $11 | +441.87% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +491.13% | Oct 11, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +737.44% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +491.13% | Sep 16, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +638.92% | Aug 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +491.13% | Aug 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +392.61% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +491.13% | May 14, 2024 |
| Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +294.09% | May 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +491.13% | May 8, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +737.44% | Apr 3, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 → $11 | Buy | Reiterates | $12 → $11 | +441.87% | Apr 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +392.61% | Apr 3, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $18 | Strong Buy | Maintains | $25 → $18 | +786.70% | Apr 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.